pioneer 10 semaglutide Dose-response, efficacy, and safety of oral monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial PIONEER REAL Spain: A multicentre,

These cleavable linkers are particularly valuable in targeted drug delivery systems, where they enable the controlled release of therapeutic agents in specific biological environments characterized by elevated protease activity, such as tumor tissues or sites of inflammation

muciniphila correlates with iBAT temperature and GLP-1 secretion and A

Obese patients with type 2 diabetes are less likely to need a CPAP machine to treat sleep apnea if theyre taking a GLP-1 drug, researchers recently reported in JAMA Network Open

Newcomers tell us we are a friendly and welcoming congregation

Where therapeutic reduction of cortisol does contribute to weight improvement for example, through treatment of confirmed endogenous Cushing's syndrome this is achieved only under specialist endocrinological care, and is not applicable as a general weight-loss strategy

Oshima N, Onimaru H, Matsubara H, Uchida T, Watanabe A, Imakiire T, et al